The perverse lottery of Novartis
The Novartis lottery is in full swing. The pharma giant raffled off a hundred times the very expensive drug Zolgensma among young children with the rare and very serious muscle disease SMA. Desperate parents and doctors have registered children for this Novartis publicity stunt and find it hard to compete in the “lottery for life. There is a good chance that a child with SMA dies before his second birthday and Zolgensma offers hope. One-year-old Jayme was in the media a lot in recent months, he could not enter the lottery and his family had started a successful crowdfunding action, supported by Dutch celebrities. But why are family and doctors faced with such major dilemmas? And why is it so expensive?
Read the full blog on our Dutch website
Do you need more information?
-
Esther de Haan
Senior Researcher
Related news
-
EU health data law rolls out the red carpet for Big TechPosted in category:Long read
Irene SchipperPublished on: -
Civil society coalition urges EU to put the interests of patients and citizens at the heart of the European Health Data SpacePosted in category:Published on:Statement
-
